Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Medulloblastoma 1

Interventions

pembrolizumab 43 Specimen Handling 39 Magnetic Resonance Spectroscopy 30 Carboplatin 30 Cyclophosphamide 27 Biopsy 25 Nivolumab 24 Dexamethasone 22 fludarabine 21 Gemcitabine 19 Bevacizumab 15 atezolizumab 14 Paclitaxel 14 Temozolomide 13 Pemetrexed 13 Ipilimumab 13 Docetaxel 13 Cisplatin 13 venetoclax 11 Rituximab 11 Prednisone 10 X-Rays 9 Lenalidomide 9 Injections 9 Fulvestrant 9 lenvatinib 8 Vincristine 8 Trastuzumab 8 Oxaliplatin 8 Fluorouracil 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Vascular Endothelial Growth Factor A × 30 days × Clear all

NCT07346157 2026-06-01

PNOC044

University of California, San Francisco

Phase 1/2 Not yet recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡